| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 287 |
| 1 | DEXAMETHASONE | 261 |
| 2 | DEXAMETHASONE 1.5 MG | 261 |
| 3 | PREDNISONE | 226 |
| 4 | LENALIDOMIDE | 189 |
| 5 | OMEPRAZOLE MAGNESIUM | 185 |
| 6 | GABAPENTIN | 178 |
| 7 | ASPIRIN | 177 |
| 8 | ACETAMINOPHEN | 174 |
| 9 | ASPIRIN 325 MG | 173 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GALSULFASE | 161 | 0.0415 |
| 1 | ELOSULFASE ALFA | 99 | 0.0179 |
| 2 | RADIUM RA 223 DICHLORIDE | 69 | 0.0136 |
| 3 | PRALATREXATE | 7 | 0.0108 |
| 4 | ERGOCALCIFEROL | 162 | 0.0054 |
| 5 | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | 2 | 0.0054 |
| 6 | SIPULEUCEL-T | 29 | 0.0050 |
| 7 | CABAZITAXEL | 17 | 0.0048 |
| 8 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 34 | 0.0045 |
| 9 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 52 | 0.0043 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 621 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 486 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 315 |
| 3 | Thalidomide Analog [EPC] | 231 |
| 4 | Opioid Agonist [EPC] | 227 |
| 5 | Benzodiazepine [EPC] | 225 |
| 6 | Proton Pump Inhibitor [EPC] | 221 |
| 7 | Kinase Inhibitor [EPC] | 188 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 187 |
| 9 | Provitamin D2 Compound [EPC] | 162 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lysosomal beta Glucuronidase [EPC] | 2 | 0.0312 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 315 | 0.0235 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 56 | 0.0096 |
| 3 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 4 | Provitamin D2 Compound [EPC] | 162 | 0.0054 |
| 5 | Autologous Cellular Immunotherapy [EPC] | 29 | 0.0050 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 7 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 8 | Lymphocyte Growth Factor [EPC] | 3 | 0.0024 |
| 9 | Non-Standardized Fungal Allergenic Extract [EPC] | 4 | 0.0019 |